We offer professional support all along the drug development life cycle, from lead optimization to Phase I clinical trials in oncology. We optimize and accelerate your R&D programs, based on our drug positioning-oriented philosophy.
Early Drug Development Group is focused on building partnerships and strategic alliances with academic research institutions, universities, governmental agencies, small size biotechnology partners and investment funds.
COLLABORATION WITH US IMPROVES YOUR RESOURCES INVESTMENT AND STRENGTHENS YOUR EARLY DRUG DEVELOPMENT PROGRAM IN ONCOLOGY.
YOUR KEY BENEFITS
• Assistance on preclinical, pharmacological and CMC approaches, clinical studies design, regulatory strategies and trials implementation to optimize and accelerate oncology R&D programs through our strong medical input and oncology-experienced staff.
• Optimization, management and execution of an efficient, customized and cost-effective development program of novel drugs through access to a highly skilled and coordinated team of world-class R&D experts.
• Broad capabilities in preclinical, pharmacokinetic and radio-pharmacology studies to guide clinical development.
• Guidance on FDA/EMA regulation and IND submission.
• Clinical Phase I study design and trial implementation.
• Due diligences on chemistry, molecular pharmacology, ADME/PK and CMC areas. Independent medical review of clinical studies data.
• Benefit from our strategic and hands-on involvement in projects which synergizes the best industry expertise with excellent cost-effective outsourced solutions to solve complex drug development challenges.
• Management for the transfer of projects from academic to company environment. Evaluation of the financial costs of pursuing a full drug development program.
Company Details
- Employees
- 1
- Founded
- 2015
- Address
- 1 Place Paul Verlaine, Boulogne Billancourt,92100,france
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- e2dg.com
- HQ
- Boulogne Billancourt
Early Drug Development Group (E2dg) Questions
Early Drug Development Group (E2Dg)'s website is e2dg.com
Early Drug Development Group (E2Dg)'s LinkedIn profile is https://fr.linkedin.com/company/early-drug-development-group
Early Drug Development Group (E2Dg) has
1 employees.
View email and phone details for 1
employees at Early Drug Development Group (E2Dg).
Early Drug Development Group (E2Dg)'s industry is
Pharmaceutical Manufacturing
Early Drug Development Group (E2Dg)'s top competitors are
Leads To Development,
Blue Bees Therapeutics,
Neoventures Biotechnology Europe,
Skin Ageing And Challenges,
Laby By Kyli,
Diaorigin Biotechnology,
Emglev Therapeutics,
Alderaan Biotechnology,
Sqy Therapeutics,
Algotx.
Early Drug Development Group (E2Dg)'s categories are Pharmaceutical Manufacturing
Early Drug Development Group (E2Dg)'s founding year is 2015
